139
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy

ORCID Icon, &
Pages 1165-1175 | Published online: 29 Apr 2020

References

  • Piccolino FC, de la Longrais RR, Ravera G, et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol. 2005;139(1):87–99. doi:10.1016/j.ajo.2004.08.037
  • Gemenetzi M, De Salvo G, Lotery AJ. Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye. 2010;24(12):1743–1756. doi:10.1038/eye.2010.130
  • Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996;103(12):2070–2079. doi:10.1016/S0161-6420(96)30386-2
  • Breukink MB, Dingemans AJ, den Hollander AI, et al. Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Clin Ophthalmol. 2017;11:39–46. doi:10.2147/OPTH.S115685
  • Wang MS, Sander B, Larsen M. Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol. 2002;133(6):787–793. doi:10.1016/S0002-9394(02)01438-1
  • Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol. 2013;41(2):201–214. doi:10.1111/j.1442-9071.2012.02848.x
  • Yannuzzi LA, Slakter JS, Kaufman SR, Gupta K. Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol. 1992;2(3):103–114. doi:10.1177/112067219200200301
  • Eandi CM, Ober M, Iranmanesh R, et al. Acute central serous chorioretinopathy and fundus autofluorescence. Retina. 2005;25(8):989–993. doi:10.1097/00006982-200512000-00006
  • von Winning CH, Oosterhuis JA, Renger-van Dijk AH, et al. Diffuse retinal pigment epitheliopathy. Ophthalmologica. 1982;185(1):7–14. doi:10.1159/000309216
  • Yang L, Jonas JB, Wei W. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2013;54(7):4659–4665. doi:10.1167/iovs.12-10991
  • Piccolino FC, De La Longrais RR, Manea M, Cicinelli S. Posterior cystoid retinal degeneration in central serous chorioretinopathy. Retina. 2008;28(7):1008–1012. doi:10.1097/IAE.0b013e31816b4b86
  • Eandi CM, Piccolino FC, Alovisi C, et al. Correlation between fundus autofluorescence and central visual function in chronic central serous chorioretinopathy. Am J Ophthalmol. 2015;159(4):652–658. doi:10.1016/j.ajo.2014.12.023
  • Zhao M, Zhang F, Chen Y, et al. A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial. JAMA Ophthalmol. 2015;133(3):333–340. doi:10.1001/jamaophthalmol.2014.5312
  • Wang M, Munch IC, Hasler PW, et al. Central serous chorioretinopathy. Acta Ophthalmol. 2008;86(2):126–145. doi:10.1111/j.1600-0420.2007.00889.x
  • Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013;58(2):103–126. doi:10.1016/j.survophthal.2012.07.004
  • Gregori NZ, Feuer W, Rosenfeld PJ. Novel method for analyzing snellen visual acuity measurements. Retina. 2010;30(7):1046–1050. doi:10.1097/IAE.0b013e3181d87e04
  • Yannuzzi LA, Shakin JL, Fisher YL, Altomonte MA. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. 1984. Retina. 2012;32(Suppl 1):1554–1572. doi:10.1097/IAE.0b013e3182434da4
  • Wong R, Chopdar A, Brown M. Five to 15 year follow-up of resolved idiopathic central serous chorioretinopathy. Eye. 2004;18(3):262–268. doi:10.1038/sj.eye.6700637
  • Loo RH, Scott IU, Flynn HW Jr., et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina. 2002;22(1):19–24. doi:10.1097/00006982-200202000-00004
  • Gallego-Pinazo R, Dolz-Marco R, Gomez-Ulla F, et al. Pachychoroid diseases of the macula. Med Hypothesis Discov Innov Ophthalmol. 2014;3(4):111–115.
  • Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment epitheliopathy. Retina. 2013;33(8):1659–1672. doi:10.1097/IAE.0b013e3182953df4
  • Agrawal R, Chhablani J, Tan KA, et al. Choroidal vasculopathy index in central serous chorioretinopathy. Retina. 2016;36(9):1646–1651. doi:10.1097/IAE.0000000000001040
  • Kim HC, Cho WB, Chung H. Morphologic changes in acute central serous chorioretinopathy using spectral domain optical coherence tomography. Korean J Ophthalmol. 2012;26(5):347–354. doi:10.3341/kjo.2012.26.5.347
  • Dansingani KK, Balaratnasingam C, Mrejen S, et al. Annular lesions and catenary forms in chronic central serous chorioretinopathy. Am J Ophthalmol. 2016;166:60–67. doi:10.1016/j.ajo.2016.03.025
  • Matet A, Daruich A, Zola M, Behar-Cohen F. Risk factors for recurrences of central serous chorioretinopathy. Retina. 2017;38:1403–1414. doi:10.1097/IAE.0000000000001729
  • Daruich A, Matet A, Dirani A, et al. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82–118. doi:10.1016/j.preteyeres.2015.05.003
  • Ozkaya A, Alkin Z, Ozveren M, et al. The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study. Eye. 2016;30(7):1005–1010. doi:10.1038/eye.2016.79
  • Ober MD, Yannuzzi LA, Do DV, et al. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology. 2005;112(12):2088–2094. doi:10.1016/j.ophtha.2005.06.026
  • Kang NH, Kim YT. Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy. Eye. 2013;27(3):387–391. doi:10.1038/eye.2012.273